Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-04-09 Hora Maninder SVP Pharma Dev & Mfg Ops Exercise or conversion +9,498 $7.21 $68K 89,759
2018-04-09 Hora Maninder SVP Pharma Dev & Mfg Ops Sale −9,498 $105.05 $998K 80,261
2018-04-09 Hora Maninder SVP Pharma Dev & Mfg Ops Exercise or conversion · Stock Option −9,498 33,002
2018-04-09 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion +49,500 $7.21 $357K 116,894
2018-04-09 Doberstein Stephen K SVP & Chief Scientific Officer Sale −49,500 $96.13 $4.8M 67,394
2018-04-09 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion · Stock Option −49,500 0
2018-04-06 GREER R SCOTT Director Exercise or conversion +30,000 $14.26 $428K 160,333
2018-04-06 GREER R SCOTT Director Sale −30,000 $92.22 $2.8M 130,333
2018-04-06 GREER R SCOTT Director Exercise or conversion · Stock Option −30,000 0
2018-04-06 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion +60,000 $10.69 $641K 127,394
2018-04-06 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion +50,000 $7.21 $361K 177,394
2018-04-06 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion +500 $7.21 $4K 177,894
2018-04-06 Doberstein Stephen K SVP & Chief Scientific Officer Sale −110,500 $91.69 $10.1M 67,394
2018-04-06 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion · Stock Option −60,000 0
2018-04-06 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion · Stock Option −50,000 0
2018-04-06 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion · Stock Option −500 49,500
2018-04-06 CHESS ROBERT Director Exercise or conversion +10,000 $14.26 $143K 284,223
2018-04-06 CHESS ROBERT Director Sale −10,000 $92.15 $922K 274,223
2018-04-06 CHESS ROBERT Director Exercise or conversion +15,000 $5.14 $77K 289,223
2018-04-06 CHESS ROBERT Director Sale −15,000 $92.14 $1.4M 274,223

Page 34 of 43 · 847 trades